Veterinary Oxygen Therapy Market Report 2025

This Veterinary Oxygen Therapy market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The veterinary oxygen therapy market size has grown strongly in recent years. It will grow from $1.17 billion in 2024 to $1.27 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to increasing demand for veterinary services, rise in pet healthcare expenditure, the prevalence of respiratory diseases in companion animals, growing demand for portable oxygen therapy solutions, and growing awareness of animal welfare.

The veterinary oxygen therapy market size is expected to see strong growth in the next few years. It will grow to $1.74 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to the growing number of pet owners, increasing adoption of pet insurance, increasing prevalence of atypical canine infectious respiratory disease, expansion of veterinary clinics and hospitals, and increasing preference for home healthcare. Major trends in the forecast period include technological advancements in veterinary oxygen therapy, technological advancements in veterinary surgical equipment, development of portable and cost-effective oxygen concentrators, innovative products with enhanced features, and advanced respiratory support systems.

The growing trend of pet adoption is anticipated to drive the expansion of the veterinary oxygen therapy market in the future. This rise in pet adoption can be attributed to various factors, including social trends, urbanization, and a notable increase in young adults postponing parenthood. Veterinary oxygen therapy serves as a vital resource for pets suffering from respiratory issues, offering pet owners reassurance by ensuring their cherished animals receive the necessary oxygen support for a quicker and more comfortable recovery. For example, in October 2023, the American Pet Products Association reported that 86.9 million households in the United States owned a pet, which represented 66% of all households in 2022. Additionally, according to Animal Medicines Australia, 69% of households in Australia had pets in 2022. Therefore, the rising trend of pet adoption is a significant factor driving the growth of the veterinary oxygen therapy market.

Key players in the veterinary oxygen therapy market are concentrating on technological innovations, such as tri-vent technology, to enhance oxygen delivery and management for animals, simplify usage for veterinarians, and improve treatment outcomes for pets and livestock. Tri-vent technology incorporates a design with three vents to optimize airflow, prevent the buildup of carbon dioxide, and enhance safety by facilitating more effective oxygen delivery and exhalation management. For example, in April 2023, Pawprint Oxygen, a U.S.-based oxygen solutions provider, launched the PureVent Pet Oxygen Mask, a specialized device aimed at pets experiencing respiratory distress. The mask boasts a triangular ergonomic shape that enhances oxygen delivery while reducing harmful gas rebreathing. This design is particularly beneficial for pets with conditions such as congestive heart failure (CHF), asthma, and laryngeal paralysis. The tri-vent system, featuring three strategically positioned vents, allows exhaled carbon dioxide (CO2) to escape without mixing with the incoming oxygen, reportedly decreasing CO2 rebreathing by as much as 80%. The PureVent Pet Oxygen Mask signifies a major advancement in veterinary care, providing a safer and more efficient method for administering oxygen to pets while ensuring their comfort and safety.

In January 2022, Novair, a medical gas systems company based in France, acquired Oxygen Generating Systems International (OGSI) for an undisclosed sum. This acquisition allows Novair to combine OGSI's technologies with its own innovations, including an advanced ionic oxygen generator created in partnership with NASA. The strategic objective behind this move is to improve the efficiency and reliability of medical oxygen supply systems in healthcare facilities. OSGI, a U.S.-based company, specializes in on-site oxygen generation systems utilizing pressure swing adsorption (PSA) technology.

Major companies operating in the veterinary oxygen therapy market are Atlas Copco AB, Smiths Group, Fisher & Paykel Healthcare, Jiangsu Yuyue Medical Equipment & Supply Co. Ltd., CAIRE Inc., Wag Labs Inc., Veterinary Specialty Center, Burtons Medical Equipment Ltd., Longfian Scitech Co. Ltd., CalOx Inc., Shinova Systems Co. Ltd., Vetland Animal Health Services Private Ltd., Airnetic LLC, Imex Medical Limited, RWD Life Science Co. Ltd., AEOLUS International Pet Products LLC, Pawprint Oxygen, New Veterinary Equipment, Avante Animal Health Inc., Vetamac Inc.

North America was the largest region in the veterinary oxygen therapy market in 2024. The regions covered in the veterinary oxygen therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary oxygen therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Veterinary oxygen therapy is a medical treatment in veterinary medicine designed to provide supplemental oxygen to animals suffering from respiratory distress, hypoxia (low blood oxygen levels), or other conditions that impair their ability to breathe effectively. The objective of oxygen therapy is to enhance the oxygen concentration in the blood, which helps vital organs function properly and supports recovery from illness or injury.

The primary products used in veterinary oxygen therapy include veterinary oxygen concentrators and associated accessories. Accessories encompass various components that aid in oxygen delivery, such as nasal cannulas, oxygen masks, humidifiers, tubing, and flow meters. Veterinary oxygen therapy is applicable to different types of animals, including small animals, large animals, and others. It is utilized in various settings, such as intensive care units (ICUs), homecare environments, postoperative care, and more. End-users of these therapies include veterinary hospitals, veterinary clinics, and other related facilities.

The veterinary oxygen therapy market research report is one of a series of new reports that provides veterinary oxygen therapy market statistics, including the veterinary oxygen therapy industry global market size, regional shares, competitors with a veterinary oxygen therapy market share, detailed veterinary oxygen therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the veterinary oxygen therapy industry. This veterinary oxygen therapy research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary oxygen therapy market consists of revenues earned by entities by providing services such as high-flow oxygen therapy, hyperbaric oxygen therapy, oxygen administration during anesthesia, standard oxygen therapy and emergency oxygen therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary oxygen therapy market also includes sales of nasal catheter, oxygen mask, oxygen chamber, oxygen tent and pure line oxygen concentrators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.